Irs-2-deficient PyV-MT-derived mammary tumor cells are significantly more sensitive to serum deprivation-induced apoptosis than wildtype tumor cells, and Irs-2-/- tumors also have a higher in situ level of apoptosis [75]. Here, IRS2 is linked to neoplasm.